Rockwell Medical Inc., based in Wixom, Michigan, focuses on development and commercialization of treatments against diseases such as end-stage renal disease  and chronic kidney disease . The company's primary customers are dialysis providers such as DaVita Inc. .

Rockwell Medical, Inc. to Present at H.C. Wainwright Annual Global Life Sciences Conference

Rockwell Medical Provides First Quarter 2022 Financial and Operational Update

Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate

Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial

Rockwell Medical Announces 1-for-11 Reverse Stock Split

Rockwell Medical, Inc. to Report First Quarter 2022 Financial and Operating Results on May 16, 2022

Perrigo (PRGO) Q1 Earnings Lag Estimates

Lantheus Holdings (LNTH) Beats Q1 Earnings and Revenue Estimates

Rockwell Medical Announces Completion of Patient Enrollment Ahead of Schedule in Pivotal Phase 3 Clinical Trial of Triferic® in China

Rockwell Medical to Present at Noblecon18 Investor Conference

Rockwell Medical Expands Partnership with DaVita

New Survey from Rockwell Medical Reveals Management of Iron Deficiency Anemia in Home Infusion Patients Does Not Adequately Address Medical Need

Rockwell Medical Announces Upcoming Poster Presentation at the National Home Infusion Associations 2022 Annual Conference

Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates

Rockwell Medical, Inc. to Present at Aegis Virtual Conference

Rockwell Medical Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rockwell Medical Announces Regulatory Approval of Triferic® Dialysate in South Korea

The Power Play by The Market Herald Releases Interview with EarthRenew, Algernon Pharmaceuticals and Rockwell Medical

Rockwell Medical Shares Surge On South Korean Approval For Iron Supplementation Therapy

Rockwell Medical Announces Regulatory Approval of Triferic® AVNU in South Korea

Rockwell Medical Inc., based in Wixom, Michigan, focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease . The company's primary customers are dialysis providers such as DaVita Inc. .

Top Streaming News